Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 AC meningococcal + Hib conjugate combined vaccine in 3–71 month-old children
CTR20171292Phase 3Completed
- Sponsor
- Zhifei Biological
- Start
- Dec 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal groups a and c and haemophilus b conjugate vaccine in meningococcal disease, meningococcal group C disease, Haemophilus influenzae type b disease (Hib), sponsored by Zhifei Biological. Started Dec 2017; status: completed.
02
Drugs
meningococcal groups a and c and haemophilus b conjugate vaccine
03
Conditions
meningococcal diseasemeningococcal group C diseaseHaemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on CTR20171292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171292.